Yao Chang Xu
Chief Executive Officer presso ABBISKO CAYMAN LIMITED
Patrimonio netto: 31 M $ in data 31/03/2024
Posizioni attive di Yao Chang Xu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ABBISKO CAYMAN LIMITED | Chief Executive Officer | 28/03/2018 | - |
| Chairman | 28/03/2018 | - | |
| Founder | 12/04/2016 | - | |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Chief Executive Officer | 12/04/2016 | - |
| Chairman | 12/04/2016 | - | |
| Founder | 12/04/2016 | - | |
| Abbisko Hong Kong Ltd. | Director/Board Member | 01/04/2018 | - |
| Wuxi Abbisko Biomedical Technology Co. Ltd. | Director/Board Member | 01/07/2020 | - |
| Abbisko Therapeutics Australia Pty Ltd. | Director/Board Member | 01/12/2020 | - |
Storia della carriera di Yao Chang Xu
Precedenti posizioni note di Yao Chang Xu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Corporate Officer/Principal | 01/03/2012 | 01/03/2016 |
| Shanghai Hansoh Biomedical Co. Ltd. | Corporate Officer/Principal | 01/03/2012 | 01/03/2016 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Director/Board Member | 01/01/2006 | 01/03/2012 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/10/1993 | 01/01/2006 |
Formazione di Yao Chang Xu
| The University of Chicago | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 6 |
| Stati Uniti | 3 |
| Svizzera | 2 |
Posizioni
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Health Technology |
| ABBISKO CAYMAN LIMITED | Health Technology |
| Aziende private | 6 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Hansoh Biomedical Co. Ltd. | |
| Abbisko Hong Kong Ltd. | |
| Wuxi Abbisko Biomedical Technology Co. Ltd. | |
| Abbisko Therapeutics Australia Pty Ltd. |
- Borsa valori
- Insiders
- Yao Chang Xu
- Esperienza
